DIA India Annual Meeting - 2025

This session will explore the evolving regulatory landscape in India, focusing on how policy developments, digital transformation, and regulatory reforms are shaping the future of pharmaceutical and biopharmaceutical oversight. Special focus is on regulatory challenges for start-up innovations and new academia-industry partnerships. With an emphasis on enhancing compliance standards while fostering innovation, it will highlight recent initiatives by Indian regulatory bodies, and other key stakeholders. Topics will include efforts to streamline clinical trial approvals, digitize regulatory submissions, and align with international standards. Through expert insights and real-world case studies, the discussion will delve into the practical aspects of maintaining regulatory compliance in a fast-evolving environment, while also encouraging scientific progress and patient access to new therapies. This session is essential for members of innovative start-ups, regulatory professionals, policy makers, and industry leaders navigating the dynamic Indian regulatory ecosystem in healthcare and pharmaceutical world